Caoimhghín Ó Caoláin
Question:179. Deputy Caoimhghín Ó Caoláin asked the Minister for Health in view of the fact that the ESRI report, Delivery of Pharmaceuticals in Ireland - Getting a Bigger Bang for the Buck, published in January 2012, stated that prices of new pharmaceuticals, subject to patent protection, could be reduced further by setting the ex-factory price with reference to the lowest-priced comparator member state and that an examination of data from recent years suggests prices would decline by 20% to 25% if such an approach were adopted, to quantify the savings which could be made by introducing this measure with immediate effect; and if he will make a statement on the matter. [30463/14]
View answer